These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 12876550)

  • 21. [From gene to disease; presenilins and Alzheimer disease].
    Roos RA; Cruts M
    Ned Tijdschr Geneeskd; 2001 Oct; 145(42):2027-9. PubMed ID: 11695101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical characterization of a presenilin 1 mutation (F177S) in a family with very early-onset Alzheimer's disease in the third decade of life.
    Hausner L; Tschäpe JA; Schmitt HP; Hentschel F; Hartmann T; Frölich L
    Alzheimers Dement; 2014 Mar; 10(2):e27-39. PubMed ID: 23850332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of ninjin'yoeito, a Kampo (traditional Japanese) medicine, on cognitive impairment and depression in patients with Alzheimer's disease: 2 years of observation.
    Kudoh C; Arita R; Honda M; Kishi T; Komatsu Y; Asou H; Mimura M
    Psychogeriatrics; 2016 Mar; 16(2):85-92. PubMed ID: 25918972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presenilin 1 gene mutation (M139I) in a patient with an early-onset Alzheimer's disease: clinical characteristics and genetic identification.
    Kim HJ; Kim HY; Ki CS; Kim SH
    Neurol Sci; 2010 Dec; 31(6):781-3. PubMed ID: 20213228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alzheimer's disease phenotypes and genotypes associated with mutations in presenilin 2.
    Jayadev S; Leverenz JB; Steinbart E; Stahl J; Klunk W; Yu CE; Bird TD
    Brain; 2010 Apr; 133(Pt 4):1143-54. PubMed ID: 20375137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical presentation of Moroccan cases with Alzheimer's disease].
    El Kadmiri N; Zaid Y; Hamzi K; Nadifi S; Slassi I; El Moutawakil B
    Encephale; 2014 Dec; 40(6):481-6. PubMed ID: 25127896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early diagnosis and the clinical genetics of Alzheimer's disease.
    Lovestone S
    J Neurol; 1999 Feb; 246(2):69-72. PubMed ID: 10195399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Genetic factors and a polygenic model of Alzheimer's disease].
    Rogaev EI
    Genetika; 1999 Nov; 35(11):1558-71. PubMed ID: 10624576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Familial Alzheimer's disease with presenilin 2 N141I mutation. A case report].
    Nikisch G; Wiedemann G; Kiessling B; Hertel A
    Fortschr Neurol Psychiatr; 2008 Oct; 76(10):606-9. PubMed ID: 18833506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mutation of presenilin ++ genes and their role in pathogenesis of Alzheimer's disease].
    Kowalska A; Wender M
    Neurol Neurochir Pol; 1998; 32(5):1207-17. PubMed ID: 10463234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3-year study of donepezil therapy in Alzheimer's disease: effects of early and continuous therapy.
    Winblad B; Wimo A; Engedal K; Soininen H; Verhey F; Waldemar G; Wetterholm AL; Haglund A; Zhang R; Schindler R
    Dement Geriatr Cogn Disord; 2006; 21(5-6):353-63. PubMed ID: 16508298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotypic profile of early-onset familial Alzheimer's disease caused by presenilin-1 E280A mutation.
    Sepulveda-Falla D; Glatzel M; Lopera F
    J Alzheimers Dis; 2012; 32(1):1-12. PubMed ID: 22766738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive stimulation therapy for Alzheimer's disease: the effect of cognitive stimulation therapy on the progression of mild Alzheimer's disease in patients treated with donepezil.
    Matsuda O
    Int Psychogeriatr; 2007 Apr; 19(2):241-52. PubMed ID: 17005066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin E and donepezil for the treatment of mild cognitive impairment.
    Petersen RC; Thomas RG; Grundman M; Bennett D; Doody R; Ferris S; Galasko D; Jin S; Kaye J; Levey A; Pfeiffer E; Sano M; van Dyck CH; Thal LJ;
    N Engl J Med; 2005 Jun; 352(23):2379-88. PubMed ID: 15829527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Neurobiology and modern approaches to the treatment of Alzheimer disease].
    Levada OA
    Lik Sprava; 2003; (7):12-6. PubMed ID: 14723127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of donepezil in Alzheimer's disease - results from a multinational trial.
    Burns A; Rossor M; Hecker J; Gauthier S; Petit H; Möller HJ; Rogers SL; Friedhoff LT
    Dement Geriatr Cogn Disord; 1999; 10(3):237-44. PubMed ID: 10325453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease.
    Rodriguez-Vieitez E; Saint-Aubert L; Carter SF; Almkvist O; Farid K; Schöll M; Chiotis K; Thordardottir S; Graff C; Wall A; Långström B; Nordberg A
    Brain; 2016 Mar; 139(Pt 3):922-36. PubMed ID: 26813969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic and pharmacodynamic evaluation of donepezil for the treatment of Alzheimer's disease.
    Prvulovic D; Schneider B
    Expert Opin Drug Metab Toxicol; 2014 Jul; 10(7):1039-50. PubMed ID: 24785550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The AAP and PS1/2 mutations linked to early onset familial Alzheimer's disease increase the extracellular concentration and A beta 1-42 (43)].
    Younkin SG
    Rinsho Shinkeigaku; 1997 Dec; 37(12):1099. PubMed ID: 9577655
    [No Abstract]   [Full Text] [Related]  

  • 40. [Alzheimer's disease and genetic factors].
    Leuba G; Savioz A
    Rev Med Suisse Romande; 1997 Nov; 117(11):871-8. PubMed ID: 9471651
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.